-

Global Encryption Software Market (2020 to 2025) - Increased Adoption of Encryption Software Across Verticals Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Encryption Software Market by Component (Software and Services), Application (Disk Encryption, File/Folder Encryption, Communication Encryption, Cloud Encryption), Deployment Mode, Enterprise Size, Vertical, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global encryption software market size is expected to grow from USD 9,763 million in 2020 to USD 20,052 million by 2025, at a Compound Annual Growth Rate (CAGR) of 15.5% from 2020 to 2025 in the post-COVID-19 scenario.

The global encryption software market size to grow at a Compound Annual Growth Rate (CAGR) of 15.5% during the forecast period

Major growth drivers for the encryption software market include stringent regulatory standards and data privacy compliances, rising concerns about loss of critical data and an exponential increase in the adoption of cloud and virtualization technologies. Budgetary constraints and availability of free, open source, and pirated encryption software may restrain the growth of the encryption software market.

Services segment to grow at a higher CAGR during the forecast period

The encryption software market is segmented on the basis of components (software and services). The services segment is expected to grow at a faster pace during the forecast period. There is a strong requirement for encryptio3en software related services to tackle specific needs. The encryption services enhance the security portfolio of enterprises and safeguard their system from unauthorized access, exploitation, and data loss.

The cloud encryption segment to grow at the highest CAGR during the forecast period

The encryption software market by application has subsegments of disk encryption, file/folder encryption, database encryption, communication encryption, and cloud encryption. The cloud encryption segment to grow at the highest CAGR during the forecast period, owing to the increasing number of organizations moving toward the cloud for achieving cost savings, agility, and flexibility, although this is also making their critical data more vulnerable to cyberattacks. Hence, the cloud encryption segment is growing at the highest rate among all encryption software applications.

Asia Pacific (APAC)to grow at the highest CAGR during the forecast period

APAC is expected to grow at the highest CAGR during the forecast period. The increasing investments by the tech companies in major APAC countries, such as India, Australia, andNew Zealand, and growing government regulations are expected to drive the growth of the market in APAC.

Market Dynamics

Drivers

  • Stringent Regulatory Standards and Data Privacy Compliances
  • Rising Concerns Pertaining to Loss of Critical Data
  • Exponential Increase in the Adoption of Cloud and Virtualization Technologies

Restraints

  • Budgetary Constraints
  • Availability of Free, Open Source, and Pirated Encryption Software

Opportunities

  • Rise in Demand for Integrated Data Protection Solutions and Eaas Among Smes
  • Increased Adoption of Encryption Software Across Verticals

Challenges

  • Difficulties in Effective Management and Usage of the Encryption Key
  • Lack of Skilled Workforce Among Enterprises

Companies Profiled

  • IBM
  • Microsoft
  • Symantec
  • Thales E-Security
  • Trend Micro
  • Sohpos
  • Check Point
  • Micro Focus
  • Mcafee
  • Dell
  • Winmagic
  • Eset
  • Cryptomathic
  • Bitdefender
  • Stormshield
  • Ciphercloud

For more information about this report visit https://www.researchandmarkets.com/r/k3j45i

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom